HIF-1: a target for cancer, ischemia and inflammation--too good to be true?
Melillo
Giovanni
G
Developmental Therapeutics Program, Science Applications International Corporation, Frederick, Inc, National Cancer Institute, Frederick, Maryland 21702, USA. melillog@ncifcrf.gov
D000818:Animals; D002465:Cell Movement / Q000502:physiology; D004268:DNA-Binding Proteins / Q000378:metabolism*; D005786:Gene Expression Regulation / Q000235:genetics / Q000502:physiology; D018257:Helix-Loop-Helix Motifs / Q000502:physiology; D051793:Hypoxia-Inducible Factor 1; D007249:Inflammation / Q000378:metabolism*; D007511:Ischemia / Q000378:metabolism*; D009369:Neoplasms / Q000378:metabolism*; D009687:Nuclear Proteins / Q000378:metabolism*; D014157:Transcription Factors
D004268:DNA-Binding Proteins; D051793:Hypoxia-Inducible Factor 1; D009687:Nuclear Proteins; D014157:Transcription Factors